New 'Living Drug' trial offers hope for patients with Hard-to-Treat leukemia
Disease control
Recruiting now
This is the first study in people testing a new type of CAR-T cell therapy called OC-1. It aims to see if this treatment is safe and can help control aggressive T-cell blood cancers (leukemia or lymphoma) that have come back or not responded to other treatments. The study will en…
Phase: PHASE1 • Sponsor: OneChain Immunotherapeutics • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC